Thymic stromal lymphopoietin (TSLP) signals via a receptor comprising the interleukin (IL)-7 receptor α chain and a distinctive subunit, TSLP receptor (TSLPR), which is most related to the common cytokine receptor γ chain, γc. We have generated TSLPR knockout (KO) mice and found that although these mice had normal lymphocyte numbers, γc/TSLPR double KO mice had a greater lymphoid defect than γc KO mice. This indicates that TSLP contributes to lymphoid development and accounts for some of the residual lymphoid development in γc KO mice and presumably in patients with X-linked severe combined immunodeficiency. Injection of TSLP into γc KO mice induced the expansion of T and B cells. Moreover, sublethally irradiated TSLPR KO mice showed weaker recovery of lymphocyte populations than wild-type (WT) littermates, even when neutralizing anti–IL-7 antibodies were injected. Interestingly, TSLP preferentially stimulated the proliferation and survival of CD4+ single positive thymocytes and peripheral T cells in vitro. Additionally, CD4+ T cells from TSLPR KO mice expanded less efficiently than WT CD4+ T cells in irradiated hosts, and TSLP preferentially expanded CD4+ T cells both in vitro and in vivo. Thus, as compared with other known cytokines, TSLP is distinctive in exhibiting a lineage preference for the expansion and survival of CD4+ T cells.
Skip Nav Destination
Article navigation
19 July 2004
Article|
July 19 2004
A Role for Thymic Stromal Lymphopoietin in CD4+ T Cell Development
Amin Al-Shami,
Amin Al-Shami
1Laboratory of Molecular Immunology
Search for other works by this author on:
Rosanne Spolski,
Rosanne Spolski
1Laboratory of Molecular Immunology
Search for other works by this author on:
John Kelly,
John Kelly
1Laboratory of Molecular Immunology
Search for other works by this author on:
Terry Fry,
Terry Fry
2Pediatric Oncology Branch, National Cancer Institute,
Search for other works by this author on:
Pamela L. Schwartzberg,
Pamela L. Schwartzberg
3The National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892
Search for other works by this author on:
Akhilesh Pandey,
Akhilesh Pandey
4McKusick-Nathans Institute of Genetic Medicine, John Hopkins University, Baltimore, MD 21287
Search for other works by this author on:
Crystal L. Mackall,
Crystal L. Mackall
2Pediatric Oncology Branch, National Cancer Institute,
Search for other works by this author on:
Warren J. Leonard
Warren J. Leonard
1Laboratory of Molecular Immunology
Search for other works by this author on:
Amin Al-Shami
1Laboratory of Molecular Immunology
Rosanne Spolski
1Laboratory of Molecular Immunology
John Kelly
1Laboratory of Molecular Immunology
Terry Fry
2Pediatric Oncology Branch, National Cancer Institute,
Pamela L. Schwartzberg
3The National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892
Akhilesh Pandey
4McKusick-Nathans Institute of Genetic Medicine, John Hopkins University, Baltimore, MD 21287
Crystal L. Mackall
2Pediatric Oncology Branch, National Cancer Institute,
Warren J. Leonard
1Laboratory of Molecular Immunology
Address correspondence to Warren J. Leonard, Laboratory of Molecular Immunology, Building 10, Room 7N252, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 496-0098; Fax: (301) 402-0971; e-mail: [email protected]
The online version of this article contains supplemental material.
Abbreviations used in this paper: BrdU, 5-bromo-2′-deoxyuridine; CFSE, carboxyfluorescein succinimidyl ester; DKO, double KO; DN, double negative; DP, double positive; ES, embryonic stem; SP, single positive; TSLP, thymic stromal lymphopoietin.
Received:
November 17 2003
Accepted:
June 02 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (2): 159–168.
Article history
Received:
November 17 2003
Accepted:
June 02 2004
Citation
Amin Al-Shami, Rosanne Spolski, John Kelly, Terry Fry, Pamela L. Schwartzberg, Akhilesh Pandey, Crystal L. Mackall, Warren J. Leonard; A Role for Thymic Stromal Lymphopoietin in CD4+ T Cell Development . J Exp Med 19 July 2004; 200 (2): 159–168. doi: https://doi.org/10.1084/jem.20031975
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement